Subject
International Journal of Hematology is the official journal of the Japanese Society of Hematology. Since 2008, it has been published by Springer Japan, but used to be published by Carden Jennings. Source: Wikipedia (en)
Editions published in International Journal of Hematology 200
Too many entities requested (5195). Only 200 are displayed.
-
How we treat chronic active Epstein-Barr virus infection
-
Predictors of vasovagal reactions during preoperative autologous blood donation: a single-institution analysis
-
Bone marrow transplantation versus immunosuppressive therapy in patients with acquired severe aplastic anemia.
-
Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) after treatment for Hodgkin's lymphoma
-
Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data).
-
Quality control and assurance in hematopoietic stem cell transplantation data registries in Japan and other countries
-
Scripts for TRUMP data analyses. Part II (HLA-related data): statistical analyses specific for hematopoietic stem cell transplantation
-
TET2 gene mutation is unfavorable prognostic factor in cytogenetically normal acute myeloid leukemia patients with NPM1+ and FLT3-ITD - mutations
-
Graft-versus-host disease biomarkers: omics and personalized medicine
-
Pathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of TPO receptor agonists in aplastic anemia and myelodysplastic syndromes
-
Molecular pathogenesis of multiple myeloma: basic and clinical updates
-
Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As2O 3) in acute promyelocytic leukemia
-
Incidence and survival rates of hematological malignancies in Japanese children and adolescents (2006-2010): based on registry data from the Japanese Society of Pediatric Hematology
-
Protein C anticoagulant and cytoprotective pathways
-
Outbreak of pandemic 2009 influenza A/H1N1 infection in the hematology ward: fatal clinical outcome of hematopoietic stem cell transplant recipients and emergence of the H275Y neuraminidase mutation
-
Disordered epigenetic regulation in MLL-related leukemia
-
CD56 expression in human myeloma cells derived from the neurogenic gene expression: possible role of the SRY-HMG box gene, SOX4
-
Pathophysiology of thrombotic thrombocytopenic purpura
-
Histiocytic sarcoma and underlying chronic myelomonocytic leukemia: a proposal for the developmental classification of histiocytic sarcoma
-
Thiamine-responsive megaloblastic anemia syndrome
-
Influenza A/pandemic 2009/H1N1 in the setting of allogeneic hematopoietic cell transplantation: a potentially catastrophic problem in a vulnerable population
-
Cross-reaction of antibody against Helicobacter pylori urease B with platelet glycoprotein IIIa and its significance in the pathogenesis of immune thrombocytopenic purpura
-
Hemophagocytic syndrome after hematopoietic stem cell transplantation: a prospective observational study
-
A retrospective analysis of bortezomib therapy for Japanese patients with relapsed or refractory multiple myeloma: beta2-microglobulin associated with time to progression
-
Serum sickness with an elevated level of human anti-chimeric antibody following treatment with rituximab in a child with chronic immune thrombocytopenic purpura.
-
Myeloid/NK cell acute leukemia
-
A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL.
-
Rituximab for the treatment of corticosteroid-refractory chronic graft-versus-host disease
-
A phase II, open-label, sequential-cohort, dose-escalation study of romiplostim in Japanese patients with chronic immune thrombocytopenic purpura
-
Is physical exercise possible in patients with critical cytopenia undergoing intensive chemotherapy for acute leukaemia or aggressive lymphoma?
-
Bone marrow large B cell lymphoma bearing cyclin D3 expression: clinical, morphologic, immunophenotypic, and genotypic analyses of seven patients
-
Successful treatment with rituximab of refractory idiopathic thrombocytopenic purpura in a patient with Kabuki syndrome
Subject - wd:Q6051416